Mangalam Drugs & Organics has informed that the meeting of the Board of Directors of the Company is scheduled on 14/08/2018, to approve, consider and take on record the Un-audited Financial Results along with Limited review report of the company for the quarter ended 30th June, 2018 as prescribed under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; and any other matters with the permission of the chair.
The above information is a part of company’s filings submitted to BSE.
